Testing effectiveness (Phase 2)Study completedNCT00463788
What this trial is testing
Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer
Who this might be right for
Breast Neoplasm
Merck KGaA, Darmstadt, Germany 181